All articles by GlobalData Healthcare

• 

  AD/PD 2025: Roche highlights time-to-event for assessing prasinezumab in early PD

  At the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD), Roche announced topline results of prasinezumab in patients…

• 

  AD/PD 2025: Buntanetap shows promise in early Parkinson’s with mild dementia

  At the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD), Annovis Bio announced data from its six-month, randomised,…

• 

  AD/PD 2025: Alzheon’s ALZ-801 shows promise for MCI but missed in mild Alzheimer’s

  On 1 April, at the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases, during a symposium sponsored by Alzheon,…

• 

  ACC 2025: AZD0780 shows significant LDL-C reduction in PURSUIT Phase IIb trial

  On 31 March, at the American College of Cardiology (ACC) Annual Scientific Session & Expo in Chicago, US, the findings…

• 

  Bavarian Nordic’s Jynneos highlights unmet need for mpox prevention in HIV patients

  A recent study carried out at Charité Universitätsmedizin Berlin and published in The Lancet Infectious Diseases has shown that one…